9.32 stock price up
Change
+ 0.02 (0.22%)
Volume
3,800
Exchange
NASDAQ
1:04 PM ET on Oct 30, 2014
Delayed at least 20 minutes.
Provided by eSignal.
3.38 stock price down
Change
- 0.08 (2.31%)
Volume
80,267
Exchange
TASE
3:24 PM IT on Oct 30, 2014
Delayed at least 20 minutes.
Provided by eSignal.
View all »Recent Releases

Oct 28, 2014
RedHill Biopharma to Host Third Quarter 2014 Financial Results Conference Call on November 10, 2014

Oct 22, 2014
RedHill Biopharma to Present at the 20th Annual BIO-Europe International Partnering Conference

Oct 1, 2014
IntelGenx and RedHill Biopharma Submit European Marketing Authorization Application for Migraine Drug RIZAPORT(R)

View all »Upcoming Events & Presentations

Nov 3, 2014 - Nov 5, 2014
Bio-Europe 20th Annual International Partnering Conference
Portalhaus Messe Frankfurt, Germany

Nov 10, 2014 at 9:00 AM ET
Third Quarter 2014 Financial Results Conference Call

Investor Relations (US):

Lauren Glaser
Vice President
The Trout Group LLC
Direct: +1 646 378 2972
Cell: +1 215 740 8468
email: lglaser@troutgroup.com

Investor Relations (Israel):

Eran Gabay
Vice President & Managing Director
Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
Direct: +972 (0)3 6070 591
email: erang@gk-biz.com

General:

RedHill Biopharma Ltd.
21 Ha’arba’a St., Tel-Aviv 64739, Israel
Tel: +972 (0)3 541 3131
Fax: +972 (0)3 541 3144
email: info@redhillbio.com